Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 38705160

Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2024 May 25
First author
Dreyling M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2024 May 25;403(10441):2264-2265. doi: 10.1016/S0140-6736(24)00301-5.
    note
    Source null
    related pmid
    38705162
    relationship
    Comment in

Authors and identifiers

  1. name
    Dreyling M
    type
    Author
  2. name
    Doorduijn J
    type
    Author
  3. name
    Giné E
    type
    Author
  4. name
    Jerkeman M
    type
    Author
  5. name
    Walewski J
    type
    Author
  6. name
    Hutchings M
    type
    Author
  7. name
    Mey U
    type
    Author
  8. name
    Riise J
    type
    Author
  9. name
    Trneny M
    type
    Author
  10. name
    Vergote V
    type
    Author
  11. name
    Shpilberg O
    type
    Author
  12. name
    Gomes da Silva M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Dreyling M
    type
    Author
  2. name
    Doorduijn J
    type
    Author
  3. name
    Giné E
    type
    Author
  4. name
    Jerkeman M
    type
    Author
  5. name
    Walewski J
    type
    Author
  6. name
    Hutchings M
    type
    Author
  7. name
    Mey U
    type
    Author
  8. name
    Riise J
    type
    Author
  9. name
    Trneny M
    type
    Author
  10. name
    Vergote V
    type
    Author
  11. name
    Shpilberg O
    type
    Author
  12. name
    Gomes da Silva M
    type
    Author
bibliography ids
  1. nci-bib-bc72859fc8a7f0240520d364
book metadata
content sha256
cf5ea14e72a0d873ef31073631ba3d5205099bc3269f6746ca82863337ee2dfe
document type
citation
dois
  1. 10.1016/S0140-6736(24)00184-3
electronic publication date
display
2024 May 2
precision
day
year
2024
evidence scope
bibliographic_metadata_only
id
pubmed:38705160
immutable id
pubmed:38705160@cf5ea14e72a0d873ef31073631ba3d5205099bc3269f6746ca82863337ee2dfe
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10441
name
Lancet (London, England)
nlm unique id
2985213R
pages
2293-2306
volume
403
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2024 May 25;403(10441):2264-2265. doi: 10.1016/S0140-6736(24)00301-5.
    note
    Source null
    related pmid
    38705162
    relationship
    Comment in
outcomes validated
false
pmid
38705160
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
d490b355897aab3ed42ddc4ef885921321600beb266924beb7bf2fa7859fb818
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 May 25
precision
day
year
2024
publication types
  1. Journal Article
  2. Randomized Controlled Trial
  3. Clinical Trial, Phase III
  4. Multicenter Study
  5. Research Support, Non-U.S. Gov't
  6. Equivalence Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38705160/
title
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.

Preserved source evidence · Not medical advice